1-15-1, Kitasato, Minami,
Sagamihara, Kanagawa 252-0375,
Shoto Rokubankan 4th Floor,
1-28-4, Shoto, Shibuya-ku,
Tokyo 150-0046 Japan
The 66th Annual Meeting of the Japan Society of Human Genetics and the 28th Annual Meeting of the Japanese Society for Gene Diagnosis and Therapy -Joint Conference 2021
Fumio Takada, M.D., Ph.D.
Professor and Chairman, Department of Medical Genetics and Genomics,
Kitasato University Graduate School of Medical Sciences
I am pleased to announce that I have been appointed as the President of the 66th Annual Meeting of the Japan Society of Human Genetics and the 28th Annual Meeting of the Japanese Society for Gene Diagnosis and Therapy. These two meetings will be held jointly at the PACIFICO Yokohama Conference Center from October 13 (Wed.) to 16 (Sat.), 2021.
The Japan Society of Human Genetics is an academic organization whose members are mainly basic researchers related to human genetics and medical professionals involved in clinical practice, while the Japanese Society for Gene Diagnosis and Therapy is an academic organization that comprises mainly the latter as well as representatives from various businesses involved in laboratory equipment and clinical testing. These two societies are academic organizations with their own unique aspects. However, some areas overlap so that they complement each other.
In regards to topics of concern common to both societies, in recent years, there has been the expansion of insurance coverage for the treatment of rare diseases, the rapid spread of cancer gene panel tests after they became applicable to insurance coverage, as well as the expansion of insurance coverage for the treatment of HBOC and other hereditary tumors. Not only such advancements in cancer genome medicine but also the PCR and other tests for novel coronavirus infections are expanding. This has led to a national push and social demand for gene-related tests, which is now rapidly increasing. At the same time, these rapid changes are causing confusion in the field, as well as a shortage of human resources for genetic and genomic medicine.
Furthermore, the worldwide ongoing dead heat in the GWAS race and the steady progress in the practical application of whole-genome sequencing analysis are opening the door to the study of multifactorial diseases and traits. In the future, AI and supercomputers will lead us into the next stage, which will reveal the diversity of life
In the midst of rapid changes, the opportunity for members of the two societies to meet and interact with each other would trigger a chemical reaction between various seeds and needs, leading to the potential to create seeds for synergistic outcomes.
The theme of this year's conference is "Solutions and Innovation" and we hope that providing opportunities for interaction, as mentioned above, to realize this theme will lead us to the next step, which has been purposefully omitted, "progress." In order to achieve this goal, we are putting our best efforts into preparations for the joint conference, hoping to bring it to fruition as a forum for encounter and exchange.
On the other hand, it is extremely difficult in January of 2021, to predict what the situation of the COVID-19 pandemic will be like in October. We are currently making preparations for the joint meeting with the aim of holding it on-site as much as possible in consideration of the above objectives. However, the number one priority is the safety of the participants, and depending on the future situation, such as the pace of vaccinations and the containment or expansion of the infection, we may consider the possibility of holding the event as a hybrid or completely online event.
We are currently living in unprecedented times that make it difficult to proceed with preparations in the face of an uncertain future. We will continue to do our utmost to make this a fruitful joint meeting for the members of both societies, hence we ask for your support for the upcoming meeting in October.
Hereafter, we will be posting more information about the conference on our website. We sincerely look forward to seeing you there.